TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the ...
As muscles age, their cells lose the ability to regenerate and heal after injury. Cornell Engineering researchers have created the most comprehensive portrait to date of how that change, in mice, ...
Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“ Satellos ” or the “ Company ”), a clinical-stage biotechnology company ...
Replacement of skeletal muscle could be a powerful tool the treatment of muscle-wasting conditions such as Duchenne dystrophy, but only a limited number of cell types are known to have myoregenerative ...
"Sarcopenia usually takes decades to develop on Earth, and we think that microgravity may have some ability to accelerate the disease process in orders of days." In a proof-of-concept experiment to ...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies
In a recent review published in the journal Cell Metabolism, researchers elucidated mechanisms and evaluated therapies for impaired skeletal muscle regeneration in diabetes, identifying research gaps ...
Muscle-on-chip systems are three-dimensional human muscle cell bundles cultured on collagen scaffolds. A Stanford University research team sent some of these systems to the International Space Station ...
The contraction process involves interactions between actin and myosin filaments within the sarcomeres to generate force. Recent research has achieved significant advances in functional design, ...
Twenty-two patients with genetically verified LGMD2A (age 37 ± 14 years) participated in this study described in (Table 1) and also in two previous studies. [24,25] All investigations were performed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results